A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2006
12/27/2006	CN1883527A A health product of lucid ganoderma and preparation method thereof
12/27/2006	CN1883518A Ganoderma spore tablet and preparation process thereof
12/27/2006	CN1883505A Method for extracting active substances from cow colostrums and equipment therefor
12/27/2006	CN1883500A Application of low molecular weight citrus pectin in increasing immunity
12/27/2006	CN1883481A Composition of leukotrienes antagonist oral liquid
12/27/2006	CN1883480A A pharmaceutical composition containing rupatatine
12/27/2006	CN1883479A 一种定量滴剂 A quantitative drops
12/27/2006	CN1883474A A composition containing macrolide compound and porous water insoluble hydrophilic carrier
12/27/2006	CN1883307A Mixed health powder
12/27/2006	CN1292000C Nucleus factor-kB p65 subunit combination peptide, preparation and application thereof
12/27/2006	CN1291998C Ligand of NKG2D acceptor and use
12/27/2006	CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient
12/27/2006	CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry
12/27/2006	CN1291979C Imidazole compounds and their use as adenosine deaminase inhibitors
12/27/2006	CN1291757C Remedy for inflammatory bowel diseases
12/27/2006	CN1291755C Pharmaceutical compositions capable of enhancing the immunogenicity of poorly immunogenic antigens
12/27/2006	CN1291715C Pharmaceutical compositions containing epinastine and pseudoephedrine
12/26/2006	US7153963 Phenylalanine derivatives
12/26/2006	US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives
12/26/2006	US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
12/26/2006	US7153932 Immunotoxins comprising ribosome-inactivating proteins
12/26/2006	US7153887 Treatment anti-neutrophil cytoplasmic antibodies-associated vasculitis in a patient resistant to corticosteroid treatment by administering gusperimus or its salt in cycles
12/26/2006	US7153881 Compounds acting as melanocortin receptor ligands
12/26/2006	US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
12/26/2006	US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006	US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders
12/26/2006	US7153834 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/21/2006	WO2006135385A2 Antagonizing interleukin-21 receptor activity
12/21/2006	WO2006135280A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
12/21/2006	WO2006135263A1 Fibroblast growth factor receptor-5 antibodies and methods for their use
12/21/2006	WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	WO2006134937A1 Skin preparation for external use
12/21/2006	WO2006134318A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
12/21/2006	WO2006133654A1 USE OF NF-κB INHIBITOR FOR TREATING SEVERAL DISEASES
12/21/2006	WO2006133498A1 Acid addition salts of n-ethyi-n'-[2-methoxy-4-(5-methyi-4-{[(1s)-1-pyridin-3-ylbutyi]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof
12/21/2006	WO2006117885A8 External preparation for skin
12/21/2006	WO2006096461A3 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
12/21/2006	WO2006091773A3 Compositions and methods related to serpin spi6
12/21/2006	WO2005105097A3 Pyridopyrimidines for treating inflammatory and other diseases
12/21/2006	WO2005100399A3 Dr5 antibodies and uses thereof
12/21/2006	US20060287510 Crystallization of IGF-1
12/21/2006	US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006	US20060287372 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications
12/21/2006	US20060287355 Imidazo and thiazolopyridines as jak3 kinase inhibitors
12/21/2006	US20060287354 Azaindole compounds as kinase inhibitors
12/21/2006	US20060287352 Modified release compositions comprising tacrolimus
12/21/2006	US20060287338 Metalloproteinase inhibitor compounds
12/21/2006	US20060287281 Phosphohalohydrins, process for the production thereof and use thereof
12/21/2006	US20060287275 Using 5'-sulfoxyoxy adenosine in therapy for tachycardia, cardiovascular disorders, angina, myocardial infraction , antilipemic agents
12/21/2006	US20060287274 Phosphoepoxides, method for making same and uses
12/21/2006	US20060287268 Splice-region antisense composition and method
12/21/2006	US20060287235 Crystallization of IGF-1
12/21/2006	US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006	US20060286670 Transplant acceptance inducing cells of monocytic origin and their preparation and use
12/21/2006	US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006	US20060286043 Delivery of antihistamines through an inhalation route
12/21/2006	US20060286042 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone
12/21/2006	CA2612324A1 N-acyl derivatives of amino acids, a process for preparation thereof, a pharmaceutical composition and use thereof as antiallergic, anti-inflammatory and hypolipidemic agents
12/21/2006	CA2612298A1 Anti-inflammatory agents
12/21/2006	CA2612151A1 Agents and methods based on the use of the eda domain of fibronectin
12/21/2006	CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	CA2596412A1 Anti-connexin compounds and uses thereof
12/21/2006	CA2578844A1 Semi-soft c-class immunostimulatory oligonucleotides
12/21/2006	CA2574848A1 Antagonizing interleukin-21 receptor activity
12/21/2006	CA2574090A1 Methods and compositions for inducing innate immune responses
12/20/2006	EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications
12/20/2006	EP1734119A2 CD16-II variants
12/20/2006	EP1733735A2 Methods and products for inducing mucosal immunity
12/20/2006	EP1733730A2 Immunemodulating oligosaccharides
12/20/2006	EP1733726A1 Pharmaceutically active isoindoline derivatives
12/20/2006	EP1733724A1 Amino alcohol compound
12/20/2006	EP1733721A2 Use of astaxanthin or esters thereof as a phosphodiesterase inhibitor
12/20/2006	EP1732648A2 Treatment of diseases
12/20/2006	EP1732611A1 Production and use of the methotrexate-albumin conjugate as an immunosuppressive agent in gvhd
12/20/2006	EP1732588A2 Modulation of nkg2d
12/20/2006	EP1732561A1 Combination of cb2 modulators and pde4 inhibitors for use in medicine
12/20/2006	EP1732547A2 Anti-hiv quinuclidine compounds
12/20/2006	EP1732531A2 Amines and amides for the treatment of diseases
12/20/2006	EP1732384A1 Novel synthetic c-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
12/20/2006	EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
12/20/2006	EP1519745B1 Method to enhance an immune response of nucleic acid vaccination
12/20/2006	EP1511732B1 Process for the manufacture of quinoline derivatives
12/20/2006	EP1506200B1 Diazabicyclic biaryl derivatives
12/20/2006	EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors
12/20/2006	EP1401809B1 Tryptase inhibitors
12/20/2006	EP1317537B1 G-csf analog compositions and methods
12/20/2006	EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
12/20/2006	EP0972032B1 Peptides for the treatment of systemic lupus erythematosus
12/20/2006	CN1882610A High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
12/20/2006	CN1882555A 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
12/20/2006	CN1882554A Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
12/20/2006	CN1882360A The use of antibiotics as vaccine adjuvants
12/20/2006	CN1882354A 细胞因子调节剂及相关用法 Cytokines regulate agents and related usage
12/20/2006	CN1880446A Antibody complexes
12/20/2006	CN1879881A Yeast vaccine production method
12/20/2006	CN1879880A Use of immunological stimulant compoundú¿ISCOMsú®in fish immunity by oral administration and dipping bath method
12/20/2006	CN1879875A Preparations stabilized over long time
12/20/2006	CN1879855A A soft capsule of 'Xiao Chai Hu' and method for preparing same

1 ... 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 ... 1172